Brief: Vera Therapeutics Q1 EPS USD -0.56 Vs. IBES Estimate USD -0.53
09/05/2024 13:00
May 09 (Reuters) - Vera Therapeutics Q1 operating income USD -31.112 million vs. IBES estimate USD -27.9 million. * Q1 operating expenses USD 31.112 million * Q1 net income USD -28.383 million vs. IBES estimate USD -27.8 million
Recent news on Vera Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Forgent Power, Vera Bradley, Wells Fargo
U.S. STOCKS ON THE MOVE-Forgent Power, Vera Bradley, Wells Fargo
U.S. STOCKS ON THE MOVE-Eli Lilly, Waystar, Wells Fargo
U.S. STOCKS ON THE MOVE-Eli Lilly, Waystar, Sysco
Vera Therapeutics gains after kidney disease drug meets goals in confirmatory trial